Vosoritide Enrolling by Invitation Phase 3 Trials for Hypochondroplasia Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT06455059
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia